Antibe Therapeutics Inc.TSX: ATE

Antibe Therapeutics Virtually Opens The Market

· Issued by Antibe Therapeutics Inc. via CNW

TORONTO , Feb. 8, 2021 /CNW/ - Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE), and his team joined Dani Lipkin , Director, Global Business Development, TMX Group, to celebrate the company's graduation from TSX Venture Exchange to Toronto Stock Exchange and open the market.

Antibe Therapeutics is a clinical-stage biotech company developing next-generation, safer medicines for pain and inflammation. The company's proprietary drug platform is designed to overcome the gastrointestinal ulcers and bleeding associated with NSAIDs, a class of drugs used by most North Americans and by billions of people globally. https://antibethera.com/

For Market Openings: Media may pick up a feed from the TOC (television operations centre) for all market open ceremonies. The feed is named TSX Transmit 1 (SD-SDI) and is produced at the TMX Broadcast Centre and sent live to the TOC. To pick up the feed via the Dejero network, please contact avservices@tmx.com . The client feature video will begin playing on the TMX media wall at approximately 9:27 a.m. ET and the markets will open with the sound of a siren at 9:30 a.m. ET

Date: Monday, February 8, 2021
Time: 9:00am - 9:30am
Place:  Virtually Broadcast

SOURCE TMX Group Limited

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2021/08/c5852.html

View original source (CNW)Antibe Therapeutics Inc. on 6ix

Earlier from Antibe Therapeutics

Later from Antibe Therapeutics

All Antibe Therapeutics news releases